Why Shares of Allakos Are Up Wednesday. Shares of clinical-stage biotech company Allakos (NASDAQ: ALLK) were up more than 15% as of 11:40 a.m. on Wednesday.
Track Allakos Inc (ALLK) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable ...
Institutional Ownership and Shareholders. Allakos Inc. (US:ALLK) has 264 institutional owners and shareholders that have filed 13D/G or 13F forms with the ...
View live Allakos Inc. chart to track its stock's price action. Find market predictions, ALLK financials and market news.
About Institutional Holdings. Nasdaq provides the ownership stake information in a company, including the number of shares held by those institutions in a firm, ...
Allakos is developing therapeutic antibodies that selectively target eosinophils and mast cells, cells that play a significant role in many diseases.
Key Data · Open $2.7400 · Day Range 2.6800 - 2.7850 · 52 Week Range 1.4750 - 8.7300 · Market Cap $238.81M · Shares Outstanding 87.48M · Public Float 66.9M ...
UH60 Blackhawk Light String Kit ... Description: The UH60 customized Light String Kit (ALLK-60) includes the light strings listed, storage cases (ALSB-5441 & ALBB ...
SAN CARLOS, Calif. , Nov. 13, 2023 (GLOBE NEWSWIRE) -- Allakos Inc. (the “Company”) (Nasdaq: ALLK), a biotechnology company developing antibodies for the ...
Allakos Inc. Common Stock (ALLK) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.